FDA Approves Symtuza for Treatment of HIV FDA Approves Symtuza for Treatment of HIV

The FDA has approved the first protease inhibitor-based single-tablet regimen for the treatment of HIV-1 infection in treatment-naive and certain virologically suppressed adult patients.FDA Approvals

Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news